Description

Spiro[Cyclopropane-1,5(4H)-[4,7]Methano[1,2]Benzisoxazole] (9Ci) is a high-purity, advanced pharmaceutical intermediate characterized by its unique spirocyclic and fused heterocyclic structure. This compound is of significant value for research and development in medicinal chemistry, particularly in the synthesis of novel bioactive molecules. It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new therapeutic agents and complex organic syntheses.

Application

• Pharmaceutical Intermediate: A key building block in the research and synthesis of new drug candidates, especially those targeting the central nervous system.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and for constructing complex molecular architectures in drug discovery programs.
• Organic Synthesis: Serves as a versatile precursor for the preparation of other spirocyclic and bridged heterocyclic compounds in academic and industrial research.
• Agrochemical Development: Potential intermediate in the research phase for creating new active ingredients with novel modes of action.
• Material Science: Investigated for use in the development of specialty chemicals and advanced organic materials.

Basic Information

Product Name	Spiro[Cyclopropane-1,5(4H)-[4,7]Methano[1,2]Benzisoxazole] (9Ci)
CAS No.	107962-84-5
Molecular Formula	C12H11NO
Molecular Weight	185.22 g/mol
Synonyms	Spiro[cyclopropane-1,5'-[4,7]methano[1,2]benzisoxazole]; 1,5-Methano-4H-benz[4,7]isoxazolo[5,4-b]azepine; 1,5-Methano-4H-benz[4,7]isoxazolo[5,4-b]azepine, 4a,5,6,7,8,8a-hexahydro-; 4a,5,6,7,8,8a-Hexahydro-1,5-methano-4H-benz[4,7]isoxazolo[5,4-b]azepine; Spiro(cyclopropane-1,5(4H)-(4,7)methano(1,2)benzisoxazole)
EINECS	Contact for details

Quality Control

Our Spiro[Cyclopropane-1,5(4H)-[4,7]Methano[1,2]Benzisoxazole] (9Ci) is manufactured under strict quality control protocols to ensure batch-to-batch consistency and high purity suitable for research applications. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing key parameters such as assay purity and impurity profiles. Our quality commitment aligns with cGMP principles where applicable for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider under an inert atmosphere to preserve stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.